Milford, MA – Prestige Scientific is excited to announce the successfully completed search for a Chief Technology Officer with our partner, a clinical-stage biotechnology company focused on the development of cell therapies in the immunology space.
This critical hire brings over 20 years of CMC experience from a range of leading biopharmaceutical companies. Prior to joining Cabaletta, the individual was Chief Technical Operations Officer at a biopharmaceutical company, where they led CMC efforts for a novel cell therapy based on a proprietary platform. Before that, they served as Vice President of Process and Analytical Development at an oncology-focused spinoff, where they were instrumental in securing approvals for three cell therapy products and advancing a preclinical product through IND clearance. Earlier in their career, they held various leadership roles in External Manufacturing, Technical Development, Manufacturing Sciences, and CMC Strategies at several companies.
This senior CMC leader will oversee the Technical Development, Manufacturing, Supply Chain, and CMC Strategy functions. They will be responsible for the entire manufacturing organization, ensuring safe and timely supply for clinical studies, readiness for commercial launch, and the implementation of continuous technological innovations to maintain competitiveness. This influential role will significantly impact the company's overall strategy and growth.
Prestige Scientific presented 10 highly qualified individuals for this role, the hired candidate was submitted 7 days from the start of the search, and the search was completed in 37 days. Congratulations to our Technical Operations and CMC team for this successful project!
About Prestige Scientific:
Prestige Scientific is an executive search firm that advises our clients on recruiting impactful leaders. We provide our clients with a performance-based hiring system that identifies leaders with past success meeting similar corporate objectives as their own, while overcoming challenges and adhering to critical timelines. We have dedicated experts in eleven practice areas that mirror a typical biopharma company, allowing us to support our client's growth from Discovery through Commercial.
